2238 Kaltenbach, Karol - Thomas Jefferson University - Thomas Jefferson University
kxk121

Karol Kaltenbach, PhD

Contact Dr. Kaltenbach

1233 Locust Street
Suite 401
Philadelphia, PA 19107

(215) 955-4068

Most Recent Peer-reviewed Publications

  1. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study
  2. Do maternal opioids reduce neonatal regional brain volumes: A pilot study
  3. Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome
  4. The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations
  5. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention
  6. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
  7. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine
  8. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression
  9. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication
  10. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
  11. Fetal assessment before and after dosing with buprenorphine or methadone
  12. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication
  13. Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review
  14. Maternal opioid treatment: Human experimental research (mother)-approach, issues and lessons learned
  15. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates
  16. Opioid dependence during pregn 0741 ancy: Relationships of anxiety and depression symptoms to treatment outcomes
  17. Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy
  18. Neonatal abstinence syndrome
  19. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus
  20. Methadone and buprenorphine for the management of opioid dependence in pregnancy
0